119 / 1224
/
Initial staging & histopathology
NSCLC cT2 cN1 cM1 (adrenal), Adeno Carcinoma
Synchronous oligo-metastatic stage IV NSCLC
EGFR, BRAF, KRAS, ERBB2, ALK, ROS1 negative
08/2015
Primary
Hilar LN
Adrenal
13.06.2016
ESTRO SBRT COURSE 2016 - Matthias Guckenberger
3